German ministry will not regulate care home reimbursement
This article was originally published in Clinica
Executive Summary
It is the job of the self-governing bodies of the health service to determine what items may be reimbursed as medical aids in care homes, and not the German ministry of health's (BMG) responsibility, says Ingeborg Lutter, deputy director of the department for nursing care at the BMG. Speaking at a MedInform conference, held under the auspices of the medical device industry association (BVMed), on the reimbursement of medical aids last week in Cologne, Ms Lutter sought to clarify an ongoing dispute between the statutory health insurance funds, patients and care homes.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.